Last edition
News about Market
Agilent to Acquire Biocare Medical
Agilent Technologies has agreed to acquire Biocare Medical, expanding its pathology portfolio with complementary antibodies, reagents and instruments. The acquisition is expected to strengthen Agilent’s revenue growth, margin profile and non-instrument revenue mix from the first year.
Market | 11/03/2026 | By News Bureau
Jiahui International Cancer Centre in Shanghai treats a US patient with advanced Non?Small Cell Lung Cancer using Ivonescimab, an experimental immunotherapy currently available only in China.
Market | 09/03/2026 | By News Bureau
Hopewell Therapeutics and Foxcroft Therapeutics partner to advance cancer vaccines using tissue-targeting lipid nanoparticles, enabling improved delivery systems with large-animal trials planned later in 2026.
Market | 09/03/2026 | By News Bureau | 186
Alembic Pharmaceuticals reports first prescription sale of Pivya in the US, marking its entry into the branded pharmaceutical segment with a first-line oral antibiotic for uncomplicated urinary tract infections in women.
Market | 07/03/2026 | By News Bureau | 122
Women's Leadership in UK Biotech Stagnates Despite Strong Funding Wins by Female CEOs: BIA Report
A new BioIndustry Association report finds women’s representation in UK biotech leadership largely unchanged, with female CEOs at 18.7 percent, while funding gains remain concentrated among a few standout companies.
Market | 06/03/2026 | By News Bureau | 121
Archimedis Digital Report Finds Indian Pharma Accelerating Digital Transformation of Quality Systems
A study by Archimedis Digital shows Indian pharma companies increasingly adopting cloud, automation and AI-driven quality systems, though digital maturity remains uneven across organisations transitioning from paper-based processes.
Market | 06/03/2026 | By News Bureau | 201
Octane Medical Group to Acquire Personalised Medicine Unit from Lonza
Octane Medical Group has signed an agreement to acquire the personalised medicine business of Lonza, including the Cocoon cell-therapy platform. The deal aims to expand Octane’s capabilities in advanced therapies and strengthen its presence in the rapidly growing personalised medicine sector.
Market | 06/03/2026 | By News Bureau | 127
Akeso and Inovio Pharmaceuticals Partner to Develop Combination Therapy for Glioblastoma
Akeso and Inovio Pharmaceuticals have entered into a clinical collaboration to evaluate cadonilimab with INO-5412 in glioblastoma. The combination will be studied in the phase-II INSIGhT trial sponsored by Dana-Farber Cancer Institute, building on prior positive data.
Market | 05/03/2026 | By Akanki | 139
GSK completes acquisition of RAPT Therapeutics
GSK has completed the acquisition of RAPT Therapeutics, adding ozureprubart, a long-acting anti-IgE monoclonal antibody, to its pipeline. The candidate is currently in phase-II(b) development for prophylactic protection against food allergens, strengthening GSK’s immunology portfolio.
Market | 05/03/2026 | By Akanki | 114
Ono Pharmaceutical Partners with Congruence Therapeutics for Neurology and Immunology Drug Discovery
Ono Pharmaceutical has expanded its collaboration with Congruence Therapeutics, leveraging the Revenir platform to discover small molecule modulators in neurology and immunology. Ono will hold exclusive worldwide option rights for development and commercialisation of resulting candidates.
Market | 03/03/2026 | By Akanki | 136
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy